M. lignano Tomo-Seq
Mlig455 transcriptome Search Regeneration Regions Sections Download

Data search


search
Exact
Search

Results for MligTC455_14220

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_14220 7 0.16 Mlig455_011703, Mlig455_049836

Neo: -

Age: -

 ADORA2A

Mlig455_011703 {REF} {Length: 1346} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=141.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=68.3]; Olfactory receptor [PF13853.8, score=19.6]} {Human: ENSG00000128271, ADORA2A, adenosine A2a receptor, [Score=157, Expect=2e-43]; ENSG00000170425, ADORA2B, adenosine A2b receptor, [Score=152, Expect=4e-42]} {Mouse: ENSMUSG00000020178, Adora2a, adenosine A2a receptor, [Score=153, Expect=4e-42]; ENSMUSG00000018500, Adora2b, adenosine A2b receptor, [Score=152, Expect=1e-42]} {Dmel: FBgn0039747, AdoR, Adenosine receptor, [Score=144, Expect=2e-37]} {Celegans: WBGene00011878, ador-1, ADenOsine Receptor homolog, [Score=95.9, Expect=8e-22]} {Smed: dd_Smed_v6_16752_0_1, dd_Smed_v6_16752_0_1, [Score=101, Expect=2e-23]} {RNA1310_66272} {RNA815_52356}

Mlig455_049836 {REF} {Length: 1682} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=139.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=71.0]; Olfactory receptor [PF13853.8, score=19.8]} {Human: ENSG00000128271, ADORA2A, adenosine A2a receptor, [Score=155, Expect=2e-42]; ENSG00000170425, ADORA2B, adenosine A2b receptor, [Score=150, Expect=2e-41]} {Mouse: ENSMUSG00000020178, Adora2a, adenosine A2a receptor, [Score=151, Expect=2e-41]; ENSMUSG00000018500, Adora2b, adenosine A2b receptor, [Score=149, Expect=2e-41]} {Dmel: FBgn0039747, AdoR, Adenosine receptor, [Score=144, Expect=2e-37]} {Celegans: WBGene00011878, ador-1, ADenOsine Receptor homolog, [Score=93.6, Expect=5e-21]} {Smed: dd_Smed_v6_16752_0_1, dd_Smed_v6_16752_0_1, [Score=100, Expect=6e-23]} {RNA1310_66272} {RNA815_52356}

Cumulative graph for MligTC455_14220

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 - - - -
RegionR2 - - - -
RegionR3 - - - -
RegionR4 - - - -
RegionR5 - - - -
RegionR6 - - - -
RegionR7 - - - -
RegionR8 - - - -

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 - - - -
RegenerationR2 - - - -
RegenerationR3 - - - -
RegenerationR4 - - - -
RegenerationR5 - - - -
RegenerationR6 - - - -
RegenerationBL - - - -
RegenerationTP - - - -


Genes with expression patterns similar to MligTC455_14220

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_14220 7 0.16 Mlig455_011703, Mlig455_049836

Neo: -

Age: -

 ADORA2A 1 - - 1.000 - - -

Mlig455_011703 {REF} {Length: 1346} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=141.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=68.3]; Olfactory receptor [PF13853.8, score=19.6]} {Human: ENSG00000128271, ADORA2A, adenosine A2a receptor, [Score=157, Expect=2e-43]; ENSG00000170425, ADORA2B, adenosine A2b receptor, [Score=152, Expect=4e-42]} {Mouse: ENSMUSG00000020178, Adora2a, adenosine A2a receptor, [Score=153, Expect=4e-42]; ENSMUSG00000018500, Adora2b, adenosine A2b receptor, [Score=152, Expect=1e-42]} {Dmel: FBgn0039747, AdoR, Adenosine receptor, [Score=144, Expect=2e-37]} {Celegans: WBGene00011878, ador-1, ADenOsine Receptor homolog, [Score=95.9, Expect=8e-22]} {Smed: dd_Smed_v6_16752_0_1, dd_Smed_v6_16752_0_1, [Score=101, Expect=2e-23]} {RNA1310_66272} {RNA815_52356}

Mlig455_049836 {REF} {Length: 1682} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=139.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=71.0]; Olfactory receptor [PF13853.8, score=19.8]} {Human: ENSG00000128271, ADORA2A, adenosine A2a receptor, [Score=155, Expect=2e-42]; ENSG00000170425, ADORA2B, adenosine A2b receptor, [Score=150, Expect=2e-41]} {Mouse: ENSMUSG00000020178, Adora2a, adenosine A2a receptor, [Score=151, Expect=2e-41]; ENSMUSG00000018500, Adora2b, adenosine A2b receptor, [Score=149, Expect=2e-41]} {Dmel: FBgn0039747, AdoR, Adenosine receptor, [Score=144, Expect=2e-37]} {Celegans: WBGene00011878, ador-1, ADenOsine Receptor homolog, [Score=93.6, Expect=5e-21]} {Smed: dd_Smed_v6_16752_0_1, dd_Smed_v6_16752_0_1, [Score=100, Expect=6e-23]} {RNA1310_66272} {RNA815_52356}
2. MligTC455_25416 74 1.53 Mlig455_023019, Mlig455_023116

Neo: -

Age: -

 KCNK18 0.999 - - 0.999 - - -

Mlig455_023019 {REF} {Length: 2752} {Pfam: Ion channel [PF07885.18, score=122.1]; Sodium ion transport-associated [PF06512.15, score=20.3]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=100, Expect=1e-22]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=106, Expect=8e-25]} {Dmel: FBgn0033257, sand, sandman, [Score=147, Expect=1e-39]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=157, Expect=1e-43]} {Smed: dd_Smed_v6_17586_0_1, dd_Smed_v6_17586_0_1, [Score=323, Expect=4e-107]} {RNA1509_41017} {RNA1310_13859.1} {RNA815_18063}

Mlig455_023116 {REF} {Length: 3009} {Pfam: Ion channel [PF07885.18, score=122.1]; Sodium ion transport-associated [PF06512.15, score=19.2]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [Score=100, Expect=2e-22]; ENSG00000164626, KCNK5, potassium two pore domain channel subfamily K member 5, [Score=95.1, Expect=2e-20]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=106, Expect=1e-24]} {Dmel: FBgn0033257, sand, sandman, [Score=149, Expect=3e-40]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=159, Expect=4e-44]} {Smed: dd_Smed_v6_17586_0_1, dd_Smed_v6_17586_0_1, [Score=325, Expect=1e-107]} {RNA1509_41017} {RNA1310_13859.1, RNA1509_41017} {RNA1509_41017, RNA815_18063}
3. MligTC455_13778 74 1.55 Mlig455_057444

Neo: -

Age: Up-Down-Down

 FGG 0.992 - - 0.992 - - - Mlig455_057444 {REF} {Length: 1868} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.2]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=96.3, Expect=4e-22]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=94.4, Expect=3e-21]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=92.4, Expect=1e-20]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=92.0, Expect=2e-20]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=97.4, Expect=2e-22]} {Dmel: FBgn0003326, sca, scabrous, [Score=84.0, Expect=7e-18]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=72.8, Expect=2e-14]} {RNA1509_51521} {RNA1310_49947} {RNA815_34508}
4. MligTC455_39064 110 2.28 Mlig455_000222, Mlig455_058480

Neo: Irradiation

Age: -

Region-enriched R2: 5.418/0.00017

 OSBPL1A 0.991 - - 0.991 - - -

Mlig455_000222 {REF} {Length: 2113} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_7740}

Mlig455_058480 {REF} {Length: 2888} {TRANSSPLICED} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_26411}
5. MligTC455_19795 50 1.05 Mlig455_015163, Mlig455_015285

Neo: -

Age: Up-Down-Down

 0.99 - - 0.990 - - -

Mlig455_015163 {REF} {Length: 4537} {TRANSSPLICED} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.2]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [RH, Score=366, Expect=7e-119]} {RNA1509_44797} {RNA1310_13221} {RNA815_45407}

Mlig455_015285 {REF} {Length: 4094} {TRANSSPLICED} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [RH, Score=366, Expect=9e-119]} {RNA1509_57431} {RNA1310_13221} {RNA815_45407}
6. MligTC455_42423 63 1.3 Mlig455_041414, Mlig455_041450

Neo: -

Age: -

 DTHD1 0.989 - - 0.989 - - -

Mlig455_041414 {REF} {Length: 3226} {Pfam: Death domain [PF00531.24, score=26.5]} {Human: ENSG00000197057, DTHD1, death domain containing 1, [RH, Score=100, Expect=8e-21]} {Mouse: ENSMUSG00000090326, Dthd1, death domain containing 1, [Score=78.6, Expect=2e-14]} {Smed: dd_Smed_v6_13807_0_1, dd_Smed_v6_13807_0_1, [Score=160, Expect=1e-40]} {RNA1310_77685}

Mlig455_041450 {REF} {Length: 3327} {Pfam: Death domain [PF00531.24, score=26.5]} {Human: ENSG00000197057, DTHD1, death domain containing 1, [RH, Score=98.2, Expect=3e-20]} {Mouse: ENSMUSG00000090326, Dthd1, death domain containing 1, [Score=76.6, Expect=8e-14]} {Smed: dd_Smed_v6_13807_0_1, dd_Smed_v6_13807_0_1, [RH, Score=160, Expect=2e-40]} {RNA1509_58078} {RNA1310_77685} {RNA815_43052}
7. MligTC455_41107 31 0.64 Mlig455_024003, Mlig455_055882

Neo: -

Age: -

 0.988 - - 0.988 - - -

Mlig455_024003 {REF} {Length: 1460} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=47.7]} {Smed: dd_Smed_v6_2174_0_1, dd_Smed_v6_2174_0_1, [Score=173, Expect=1e-52]} {RNA1310_46591}

Mlig455_055882 {REF} {Length: 1280} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=38.4]} {Smed: dd_Smed_v6_2174_0_1, dd_Smed_v6_2174_0_1, [Score=152, Expect=1e-44]} {RNA1310_46591}
8. MligTC455_21693 48 1 Mlig455_024307, Mlig455_024362, Mlig455_024476

Neo: -

Age: -

 AHR 0.987 - - 0.987 - - -

Mlig455_024307 {REF} {Length: 4440} {Pfam: PAS fold [PF08447.14, score=59.6]; PAS fold [PF00989.27, score=42.5]; PAS domain [PF14598.8, score=40.5]; PAS domain [PF13426.9, score=18.9]; C-terminal region of eIF3h [PF19445.1, score=18.6]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [Score=229, Expect=8e-64]; ENSG00000283321, AC019117.2, novel protein, [Score=228, Expect=1e-63]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [Score=216, Expect=2e-59]} {Dmel: FBgn0003513, ss, spineless, [Score=303, Expect=7e-91]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [Score=200, Expect=8e-56]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [Score=369, Expect=4e-118]} {RNA1310_45588}

Mlig455_024362 {REF} {Length: 4404} {Pfam: PAS fold [PF08447.14, score=59.5]; PAS fold [PF00989.27, score=43.6]; PAS domain [PF14598.8, score=41.4]; Helix-loop-helix DNA-binding domain [PF00010.28, score=27.4]; C-terminal region of eIF3h [PF19445.1, score=20.1]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [RH, Score=298, Expect=1e-88]; ENSG00000283321, AC019117.2, novel protein, [RH, Score=297, Expect=2e-88]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [RH, Score=286, Expect=2e-84]} {Dmel: FBgn0003513, ss, spineless, [RH, Score=398, Expect=1e-124]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [RH, Score=265, Expect=6e-79]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [RH, Score=503, Expect=4e-169]} {RNA1310_45588}

Mlig455_024476 {REF} {Length: 4767} {Pfam: PAS fold [PF08447.14, score=58.8]; PAS fold [PF00989.27, score=41.6]; PAS domain [PF14598.8, score=40.1]; Helix-loop-helix DNA-binding domain [PF00010.28, score=27.1]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [Score=230, Expect=4e-63]; ENSG00000283321, AC019117.2, novel protein, [Score=229, Expect=4e-63]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [Score=217, Expect=8e-59]} {Dmel: FBgn0003513, ss, spineless, [Score=303, Expect=5e-89]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [Score=199, Expect=1e-54]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [Score=373, Expect=3e-117]} {RNA1310_45588}
9. MligTC455_48435 85 1.77 Mlig455_011328

Neo: -

Age: -

 0.982 - - 0.982 - - - Mlig455_011328 {REF} {Length: 1209} {Pfam: F5/8 type C domain [PF00754.27, score=25.9]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=51.6, Expect=2e-08]} {RNA1310_39626.1} {RNA815_20659}
10. MligTC455_35802 114 2.38 Mlig455_051876, Mlig455_051902, Mlig455_053140

Neo: -

Age: -

 CACNA2D1 0.98 - - 0.980 - - -

Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380}

Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878}

Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878}
11. MligTC455_37109 33 0.68 Mlig455_060876

Neo: -

Age: -

 0.979 - - 0.979 - - - Mlig455_060876 {REF} {Length: 929} {NoTransDecoderORF} {RNA1310_114871}
12. MligTC455_45897 33 0.69 Mlig455_008231

Neo: -

Age: -

 ANGPTL2 0.979 - - 0.979 - - - Mlig455_008231 {REF} {Length: 925} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=151.2]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=131, Expect=4e-35]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=130, Expect=7e-35]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=125, Expect=7e-33]} {Mouse: ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=131, Expect=3e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=130, Expect=6e-35]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=128, Expect=3e-34]} {Dmel: FBgn0034160, CG5550, [Score=108, Expect=9e-29]} {RNA1509_26827} {RNA1310_66248} {RNA815_17173.1}
13. MligTC455_51162 19 0.4 Mlig455_031792

Neo: -

Age: -

 0.975 - - 0.975 - - - Mlig455_031792 {REF} {Length: 2044} {RNA1509_36146} {RNA1310_58551} {RNA815_37384}
14. MligTC455_18522 455 9.47 Mlig455_008847, Mlig455_008948

Neo: -

Age: logFC(26M/2M)=-0.379

 RASEF 0.974 - - 0.974 - - -

Mlig455_008847 {REF} {Length: 4934} {Pfam: Ras family [PF00071.24, score=159.8]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=100.2]; ADP-ribosylation factor family [PF00025.23, score=54.0]; EF-hand domain [PF13405.8, score=28.8]; EF-hand domain pair [PF13499.8, score=28.3]; 50S ribosome-binding GTPase [PF01926.25, score=26.0]} {Human: ENSG00000165105, RASEF, RAS and EF-hand domain containing, [Score=238, Expect=7e-67]} {Mouse: ENSMUSG00000043003, Rasef, RAS and EF hand domain containing, [RH, Score=259, Expect=4e-75]} {Dmel: FBgn0285937, Rab1, [Score=134, Expect=9e-36]} {Celegans: WBGene00016344, rsef-1, Ras and EF-hand domain-containing protein homolog, [Score=177, Expect=1e-46]} {Smed: dd_Smed_v6_12567_0_1, dd_Smed_v6_12567_0_1, [RH, Score=189, Expect=7e-51]} {RNA1310_9926} {RNA815_2505}

Mlig455_008948 {REF} {Length: 4701} {Pfam: Ras family [PF00071.24, score=159.8]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=100.2]; ADP-ribosylation factor family [PF00025.23, score=54.0]; EF-hand domain [PF13405.8, score=31.0]; EF-hand domain pair [PF13499.8, score=28.9]; 50S ribosome-binding GTPase [PF01926.25, score=25.9]; EF hand [PF00036.34, score=20.0]; EF hand [PF13202.8, score=19.4]} {Human: ENSG00000165105, RASEF, RAS and EF-hand domain containing, [Score=184, Expect=2e-48]} {Mouse: ENSMUSG00000043003, Rasef, RAS and EF hand domain containing, [RH, Score=261, Expect=7e-76]} {Dmel: FBgn0285937, Rab1, [Score=134, Expect=1e-35]} {Celegans: WBGene00016344, rsef-1, Ras and EF-hand domain-containing protein homolog, [Score=177, Expect=1e-46]} {Smed: dd_Smed_v6_12567_0_1, dd_Smed_v6_12567_0_1, [RH, Score=189, Expect=3e-51]} {RNA1310_9926} {RNA815_2505}
15. MligTC455_09455 51 1.06 Mlig455_029990

Neo: -

Age: -

Region-enriched R2: 4.710/0.00601

 0.972 - - 0.972 - - - Mlig455_029990 {REF} {Length: 3817} {Mouse: ENSMUSG00000090546, Cdr1, cerebellar degeneration related antigen 1, [Score=63.2, Expect=8e-10]} {Celegans: WBGene00013762, Y113G7B.12, [Score=58.2, Expect=2e-08]} {RNA1509_44134} {RNA1310_28496} {RNA815_11143}
16. MligTC455_13282 95 1.99 Mlig455_021294

Neo: -

Age: Down-Up-Down

 0.972 - - 0.972 - - - Mlig455_021294 {REF} {Length: 840} {NoTransDecoderORF} {RNA1310_63724} {RNA815_38056}
17. MligTC455_18607 203 4.23 Mlig455_012344, Mlig455_012722

Neo: -

Age: -

Region-enriched R2: 3.338/0.02204

 ANKRD63 0.972 - - 0.972 - - -

Mlig455_012344 {REF} {Length: 1989} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.3]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=55.5, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_1, dd_Smed_v6_11187_0_1, [Score=59.3, Expect=2e-09]} {RNA1310_37830} {RNA815_38436}

Mlig455_012722 {REF} {Length: 2256} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.2]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0031473, CG3104, [Score=54.7, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_2, dd_Smed_v6_11187_0_2, [Score=59.7, Expect=1e-09]} {RNA1310_37830} {RNA815_38436}
18. MligTC455_36377 39 0.82 Mlig455_032339

Neo: -

Age: -

 0.972 - - 0.972 - - - Mlig455_032339 {REF} {Length: 2133} {Dmel: FBgn0038397, CG10185, [Score=82.0, Expect=8e-16]} {Celegans: WBGene00020254, T05C3.2, [Score=114, Expect=6e-26]}
19. MligTC455_16248 132 2.74 Mlig455_038325, Mlig455_050222, Mlig455_050231

Neo: -

Age: -

 CHRNA3 0.971 - - 0.971 - - -

Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042}

Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042}

Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042}
20. MligTC455_20550 381 7.94 Mlig455_010388, Mlig455_028015

Neo: -

Age: -

Region-enriched R2: 1.910/0.04589

 HMCN1, HMCN2 0.97 - - 0.970 - - -

Mlig455_010388 {REF} {Length: 3305} {Pfam: Immunoglobulin domain [PF13927.8, score=93.2]; Immunoglobulin domain [PF13895.8, score=68.2]; Immunoglobulin I-set domain [PF07679.18, score=67.4]; Immunoglobulin domain [PF00047.27, score=64.7]; Fibronectin type III domain [PF00041.23, score=29.9]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=28.5]; Immunoglobulin V-set domain [PF07686.19, score=22.4]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=88.2, Expect=5e-17]; ENSG00000148357, HMCN2, hemicentin 2, [Score=85.5, Expect=3e-16]} {Mouse: ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=108, Expect=3e-23]} {Dmel: FBgn0000547, ed, echinoid, [Score=163, Expect=1e-40]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=77.8, Expect=3e-14]} {Smed: dd_Smed_v6_13903_0_1, dd_Smed_v6_13903_0_1, [Score=134, Expect=4e-32]} {RNA1310_22531.1} {RNA815_15161}

Mlig455_028015 {REF} {Length: 4677} {Pfam: Immunoglobulin domain [PF13927.8, score=161.8]; Immunoglobulin I-set domain [PF07679.18, score=106.9]; Immunoglobulin domain [PF00047.27, score=106.0]; Immunoglobulin domain [PF13895.8, score=103.4]; Immunoglobulin V-set domain [PF07686.19, score=56.4]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=48.7]; Fibronectin type III domain [PF00041.23, score=30.7]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=113, Expect=2e-24]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=135, Expect=2e-31]} {Dmel: FBgn0000547, ed, echinoid, [Score=216, Expect=7e-57]} {Celegans: WBGene00018215, igcm-1, ImmunoGlobulin-like Cell adhesion Molecule family, [Score=135, Expect=7e-32]} {Smed: dd_Smed_v6_13903_0_1, dd_Smed_v6_13903_0_1, [Score=186, Expect=7e-48]} {RNA1310_22531.1} {RNA815_15161}
21. MligTC455_47641 250 5.21 Mlig455_007026, Mlig455_069139

Neo: -

Age: Down-Up-Up

 0.97 - - 0.970 - - -

Mlig455_007026 {REF} {Length: 2110} {RNA1509_55500} {RNA1310_26431} {RNA815_24412}

Mlig455_069139 {REF} {Length: 2221} {RNA1509_55500} {RNA1310_26431, RNA1509_55500} {RNA1509_55500, RNA815_24412}
22. MligTC455_35529 117 2.43 Mlig455_020107, Mlig455_069888

Neo: -

Age: -

 0.968 - - 0.968 - - -

Mlig455_020107 {REF} {Length: 3566} {RNA1509_53783} {RNA1310_29335.1} {RNA815_9084.1}

Mlig455_069888 {REF} {Length: 2216} {RNA1509_44264} {RNA1310_56703} {RNA815_9084.1}
23. MligTC455_40780 107 2.22 Mlig455_000276, Mlig455_024108, Mlig455_035730, Mlig455_058355

Neo: -

Age: -

 0.968 - - 0.968 - - -

Mlig455_000276 {REF} {Length: 1350} {RNA1310_30070} {RNA815_59383}

Mlig455_024108 {REF} {Length: 1999} {RNA1310_30070} {RNA815_59383}

Mlig455_035730 {REF} {Length: 2143} {RNA1310_30070} {RNA815_59383}

Mlig455_058355 {REF} {Length: 1365} {RNA1310_30070} {RNA815_59383}
24. MligTC455_36047 46 0.97 Mlig455_015082

Neo: -

Age: Up-Down-Up

Region-enriched R4: 5.453/0.02503

 PLEC 0.967 - - 0.967 - - - Mlig455_015082 {REF} {Length: 8162} {Human: ENSG00000178209, PLEC, plectin, [Score=55.5, Expect=4e-07]} {Mouse: ENSMUSG00000022565, Plec, plectin, [Score=52.0, Expect=3e-06]} {Dmel: FBgn0031842, Tango1, Transport and Golgi organization 1, [Score=52.0, Expect=2e-06]} {RNA1509_55672} {RNA1310_5289} {RNA815_36944}
25. MligTC455_36048 44 0.92 Mlig455_027161

Neo: -

Age: -

Region-enriched R4: 5.254/0.03384

 0.967 - - 0.967 - - - Mlig455_027161 {REF} {Length: 671} {NoTransDecoderORF} {RNA1310_62745}
26. MligTC455_17475 56 1.16 Mlig455_065300, Mlig455_065322

Neo: -

Age: -

 MYT1L 0.964 - - 0.964 - - -

Mlig455_065300 {REF} {Length: 3149} {Pfam: Zinc finger, C2HC type [PF01530.20, score=77.6]} {Human: ENSG00000186487, MYT1L, myelin transcription factor 1 like, [RH, Score=130, Expect=2e-33]; ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=126, Expect=1e-29]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=126, Expect=1e-29]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=126, Expect=3e-30]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=125, Expect=1e-29]} {Mouse: ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=129, Expect=6e-31]; ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=125, Expect=7e-30]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=125, Expect=1e-29]} {Dmel: FBgn0263772, CG43689, [Score=87.4, Expect=1e-17]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=123, Expect=1e-29]} {Smed: dd_Smed_v6_80183_0_1, dd_Smed_v6_80183_0_1, [RH, Score=132, Expect=7e-35]} {RNA1310_120779}

Mlig455_065322 {REF} {Length: 1854} {Pfam: Zinc finger, C2HC type [PF01530.20, score=74.9]} {Human: ENSG00000186487, MYT1L, myelin transcription factor 1 like, [RH, Score=129, Expect=1e-31]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=126, Expect=3e-30]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=125, Expect=8e-30]; ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=125, Expect=8e-30]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=125, Expect=9e-30]} {Mouse: ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=128, Expect=7e-31]; ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=125, Expect=6e-30]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=124, Expect=1e-29]} {Dmel: FBgn0263772, CG43689, [Score=87.0, Expect=1e-17]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=124, Expect=2e-30]} {Smed: dd_Smed_v6_80183_0_1, dd_Smed_v6_80183_0_1, [RH, Score=133, Expect=3e-35]} {RNA1310_120779}
27. MligTC455_38031 24 0.5 Mlig455_049070

Neo: -

Age: -

 0.964 - - 0.964 - - - Mlig455_049070 {REF} {Length: 2566} {RNA1310_26848} {RNA815_42675}
28. MligTC455_42020 58 1.22 Mlig455_059333

Neo: -

Age: -

 WSCD2 0.964 - - 0.964 - - - Mlig455_059333 {REF} {Length: 1392} {Pfam: WSC domain [PF01822.21, score=60.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=48.9, Expect=1e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=48.5, Expect=1e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.5, Expect=9e-11]} {RNA1509_57286} {RNA1310_34378} {RNA815_35918}
29. MligTC455_48655 235 4.9 Mlig455_016685, Mlig455_051240

Neo: -

Age: -

 ONECUT1 0.962 - - 0.962 - - -

Mlig455_016685 {REF} {Length: 3882} {Pfam: CUT domain [PF02376.17, score=113.6]} {Human: ENSG00000169856, ONECUT1, one cut homeobox 1, [Score=214, Expect=1e-62]} {Mouse: ENSMUSG00000043013, Onecut1, one cut domain, family member 1, [Score=186, Expect=4e-52]; ENSMUSG00000045991, Onecut2, one cut domain, family member 2, [Score=185, Expect=7e-52]; ENSMUSG00000045518, Onecut3, one cut domain, family member 3, [Score=184, Expect=3e-51]} {Dmel: FBgn0028996, onecut, [Score=217, Expect=1e-60]} {Celegans: WBGene00015934, ceh-48, One cut domain family member, [Score=187, Expect=6e-53]} {Smed: dd_Smed_v6_16472_0_1, dd_Smed_v6_16472_0_1, [Score=214, Expect=2e-60]} {RNA1509_56542} {RNA1310_35187} {RNA815_16352}

Mlig455_051240 {REF} {Length: 3794} {Pfam: CUT domain [PF02376.17, score=113.5]; Homeodomain [PF00046.31, score=43.2]; Homeobox KN domain [PF05920.13, score=22.7]} {Human: ENSG00000169856, ONECUT1, one cut homeobox 1, [Score=276, Expect=8e-86]} {Mouse: ENSMUSG00000043013, Onecut1, one cut domain, family member 1, [Score=276, Expect=8e-86]} {Dmel: FBgn0028996, onecut, [Score=283, Expect=2e-83]} {Celegans: WBGene00000459, ceh-38, Homeobox protein ceh-38, [Score=201, Expect=1e-56]} {Smed: dd_Smed_v6_25197_0_2, dd_Smed_v6_25197_0_2, [Score=259, Expect=1e-76]} {RNA1509_56542} {RNA1310_35187, RNA1509_56542} {RNA1509_56542, RNA815_16352}
30. MligTC455_53339 361 7.52 Mlig455_044792, Mlig455_044816, Mlig455_055565

Neo: -

Age: -

Region-enriched R2: 2.402/0.04439

 DMBT1 0.96 - - 0.960 - - -

Mlig455_044792 {REF} {Length: 2555} {Pfam: Zona pellucida-like domain [PF00100.25, score=90.4]; Scavenger receptor cysteine-rich domain [PF00530.20, score=77.7]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=8e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=58.2, Expect=3e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.9, Expect=9e-14]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134}

Mlig455_044816 {REF} {Length: 2732} {Pfam: Zona pellucida-like domain [PF00100.25, score=89.0]; Scavenger receptor cysteine-rich domain [PF00530.20, score=78.1]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=9e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=8e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.6, Expect=1e-13]} {RNA1509_36885} {RNA1310_10008, RNA1509_36885} {RNA1509_36885, RNA815_6134}

Mlig455_055565 {REF} {Length: 2284} {Pfam: Scavenger receptor cysteine-rich domain [PF00530.20, score=79.3]; Zona pellucida-like domain [PF00100.25, score=35.8]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=65.5, Expect=1e-10]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=4e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=55.1, Expect=4e-08]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134}
31. MligTC455_17412 44 0.91 Mlig455_069737

Neo: -

Age: -

Region-enriched R2: 5.062/0.00923

 0.958 - - 0.958 - - - Mlig455_069737 {REF} {Length: 1628} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=42.8]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=72.8, Expect=3e-14]} {RNA1310_45758} {RNA815_42912}
32. MligTC455_45064 98 2.04 Mlig455_059206

Neo: -

Age: -

Region-enriched R2: 3.378/0.01843

 MTUS2 0.958 - - 0.958 - - - Mlig455_059206 {REF} {Length: 4973} {Human: ENSG00000132938, MTUS2, microtubule associated scaffold protein 2, [RH, Score=70.5, Expect=1e-11]} {Mouse: ENSMUSG00000029651, Mtus2, microtubule associated tumor suppressor candidate 2, [RH, Score=72.0, Expect=3e-12]} {Dmel: FBgn0015600, toc, toucan, [RH, Score=58.5, Expect=3e-08]} {RNA1509_44985, RNA1509_58911} {RNA1310_13922.1, RNA1509_44985} {RNA1509_44985, RNA815_11784}
33. MligTC455_48229 140 2.92 Mlig455_025844

Neo: -

Age: -

 0.958 - - 0.958 - - - Mlig455_025844 {REF} {Length: 3215} {Pfam: Domain of unknown function (DUF4139) [PF13598.8, score=115.0]} {Celegans: WBGene00016877, C52D10.3, [Score=176, Expect=4e-49]} {Smed: dd_Smed_v6_3629_0_1, dd_Smed_v6_3629_0_1, [Score=280, Expect=3e-88]} {RNA1509_25634} {RNA1310_6356.2} {RNA815_15997}
34. MligTC455_07101 46 0.96 Mlig455_062761

Neo: -

Age: Down-Up-Down

 POU4F1 0.957 - - 0.957 - - - Mlig455_062761 {REF} {Length: 2816} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=109.3]; Homeodomain [PF00046.31, score=67.1]; Helix-turn-helix domain [PF13560.8, score=22.0]} {Human: ENSG00000152192, POU4F1, POU class 4 homeobox 1, [RH, Score=271, Expect=7e-87]; ENSG00000151615, POU4F2, POU class 4 homeobox 2, [RH, Score=269, Expect=4e-86]; ENSG00000091010, POU4F3, POU class 4 homeobox 3, [RH, Score=267, Expect=2e-86]} {Mouse: ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [RH, Score=271, Expect=6e-87]; ENSMUSG00000031688, Pou4f2, POU domain, class 4, transcription factor 2, [RH, Score=268, Expect=3e-86]; ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [RH, Score=266, Expect=2e-86]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [RH, Score=265, Expect=3e-85]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [RH, Score=236, Expect=4e-75]} {Smed: dd_Smed_v6_15555_0_1, dd_Smed_v6_15555_0_1, [RH, Score=305, Expect=5e-101]} {RNA1509_57422} {RNA1310_8139.2} {RNA815_32659}
35. MligTC455_45919 242 5.04 Mlig455_040207

Neo: -

Age: -

 PLSCR1 0.957 - - 0.957 - - - Mlig455_040207 {REF} {Length: 2652} {Pfam: Scramblase [PF03803.17, score=245.9]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=241, Expect=1e-77]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=231, Expect=8e-74]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=227, Expect=2e-72]} {Dmel: FBgn0052056, scramb1, scramblase 1, [RH, Score=241, Expect=2e-76]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=191, Expect=3e-59]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=297, Expect=6e-100]} {RNA1509_25839} {RNA1310_11207.1} {RNA815_13677}
36. MligTC455_12812 58 1.21 Mlig455_027688, Mlig455_047749

Neo: -

Age: Up-Down-Down

 0.956 - - 0.956 - - -

Mlig455_027688 {REF} {Length: 2289} {Pfam: Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=18.6]} {RNA1509_59038} {RNA1310_64936.1, RNA1509_59038}

Mlig455_047749 {REF} {Length: 2332} {RNA1509_59038} {RNA1310_67234}
37. MligTC455_40290 58 1.21 Mlig455_058728

Neo: -

Age: -

Region-enriched R2: 4.464/0.00807
Region-enriched R7: 3.833/0.03206

 0.956 - - 0.956 - - - Mlig455_058728 {REF} {Length: 1351} {Pfam: CUB domain [PF00431.22, score=48.4]} {RNA1310_48745} {RNA815_23305}
38. MligTC455_53092 129 2.68 Mlig455_062642

Neo: -

Age: -

 SPATA1 0.956 - - 0.956 - - - Mlig455_062642 {REF} {Length: 4411} {Pfam: Spermatogenesis-associated C-terminus [PF15743.7, score=137.7]} {Human: ENSG00000122432, SPATA1, spermatogenesis associated 1, [Score=103, Expect=2e-22]} {Mouse: ENSMUSG00000028188, Spata1, spermatogenesis associated 1, [Score=103, Expect=6e-23]} {Smed: dd_Smed_v6_15381_0_1, dd_Smed_v6_15381_0_1, [RH, Score=174, Expect=1e-46]} {RNA1509_56521} {RNA1310_8534} {RNA815_3401.1}
39. MligTC455_37848 42 0.87 Mlig455_049400

Neo: -

Age: -

 0.955 - - 0.955 - - - Mlig455_049400 {REF} {Length: 2374} {RNA1509_58287} {RNA1310_1148.1} {RNA815_900}
40. MligTC455_40075 72 1.5 Mlig455_003636, Mlig455_003841

Neo: -

Age: -

 0.955 - - 0.955 - - -

Mlig455_003636 {REF} {Length: 1017} {Pfam: PAN domain [PF00024.28, score=20.3]} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [RH, Score=69.7, Expect=2e-14]} {RNA1310_45613} {RNA815_17816.1}

Mlig455_003841 {REF} {Length: 978} {TRANSSPLICED} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [RH, Score=70.5, Expect=1e-14]} {RNA1310_45613} {RNA815_17816.1}
41. MligTC455_17520 34 0.71 Mlig455_022340

Neo: -

Age: -

 0.954 - - 0.954 - - - Mlig455_022340 {REF} {Length: 878} {Pfam: WSC domain [PF01822.21, score=52.4]; PAN domain [PF00024.28, score=24.0]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=50.4, Expect=3e-07]} {RNA1509_43359} {RNA1310_27550.1} {RNA815_22520}
42. MligTC455_16243 108 2.26 Mlig455_063048

Neo: -

Age: -

 0.953 - - 0.953 - - - Mlig455_063048 {REF} {Length: 2934} {TRANSSPLICED} {RNA1509_56072} {RNA1310_35648.1, RNA1509_56072} {RNA1509_56072, RNA815_22277}
43. MligTC455_33353 166 3.46 Mlig455_007629, Mlig455_058320

Neo: -

Age: -

 0.952 - - 0.952 - - -

Mlig455_007629 {REF} {Length: 1589} {TRANSSPLICED} {Pfam: GIY-YIG catalytic domain [PF01541.26, score=24.4]} {Smed: dd_Smed_v6_129_2_1, dd_Smed_v6_129_2_1, [Score=46.2, Expect=3e-06]} {RNA1509_36216} {RNA1310_50399.2} {RNA815_22235.1}

Mlig455_058320 {REF} {Length: 184} {NoTransDecoderORF} {RNA1310_73857} {RNA815_48208}
44. MligTC455_13403 157 3.27 Mlig455_058321

Neo: -

Age: Down-Up-Down

Region-enriched R2: 2.878/0.03174

 LARP1 0.95 - - 0.950 - - - Mlig455_058321 {REF} {Length: 2328} {Human: ENSG00000155506, LARP1, La ribonucleoprotein domain family member 1, [Score=178, Expect=6e-52]} {Mouse: ENSMUSG00000037331, Larp1, La ribonucleoprotein domain family, member 1, [Score=178, Expect=5e-52]; ENSMUSG00000025762, Larp1b, La ribonucleoprotein domain family, member 1B, [Score=171, Expect=9e-54]} {Dmel: FBgn0261618, larp, La related protein, [Score=172, Expect=4e-50]} {Celegans: WBGene00020097, larp-1, La-related protein 1, [Score=136, Expect=2e-37]} {Smed: dd_Smed_v6_2667_0_1, dd_Smed_v6_2667_0_1, [Score=170, Expect=2e-49]} {RNA1509_29509} {RNA1310_3597.2, RNA1509_29509} {RNA1509_29509, RNA815_2607}
45. MligTC455_15720 37 0.78 Mlig455_000177

Neo: -

Age: Up-Down-Down

 TRPC3 0.95 - - 0.950 - - - Mlig455_000177 {REF} {Length: 4780} {Pfam: Transient receptor ion channel II [PF08344.13, score=91.7]; Ion transport protein [PF00520.33, score=56.1]; Ankyrin repeats (3 copies) [PF12796.9, score=34.0]; Ankyrin repeat [PF13606.8, score=29.0]; Ankyrin repeat [PF00023.32, score=24.2]} {Human: ENSG00000138741, TRPC3, transient receptor potential cation channel subfamily C member 3, [Score=517, Expect=2e-166]; ENSG00000137672, TRPC6, transient receptor potential cation channel subfamily C member 6, [Score=506, Expect=2e-162]; ENSG00000069018, TRPC7, transient receptor potential cation channel subfamily C member 7, [Score=506, Expect=4e-163]} {Mouse: ENSMUSG00000027716, Trpc3, transient receptor potential cation channel, subfamily C, member 3, [Score=511, Expect=2e-164]; ENSMUSG00000021541, Trpc7, transient receptor potential cation channel, subfamily C, member 7, [Score=507, Expect=2e-163]; ENSMUSG00000031997, Trpc6, transient receptor potential cation channel, subfamily C, member 6, [Score=501, Expect=1e-160]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [Score=451, Expect=1e-139]} {Celegans: WBGene00006614, trp-1, Transient-receptor-potential-like protein, [Score=448, Expect=9e-140]} {Smed: dd_Smed_v6_13048_0_2, dd_Smed_v6_13048_0_2, [RH, Score=1276, Expect=0.0]} {RNA1509_39636} {RNA1310_5314} {RNA815_4923}
46. MligTC455_33039 312 6.51 Mlig455_032494

Neo: -

Age: Up-Down-Down

Region-enriched R2: 3.545/0.00267

 PKDREJ 0.95 - - 0.950 - - - Mlig455_032494 {REF} {Length: 11952} {Pfam: Polycystin cation channel [PF08016.14, score=289.9]; REJ domain [PF02010.17, score=90.4]; PLAT/LH2 domain [PF01477.25, score=68.4]; PKD domain [PF00801.22, score=57.9]; PKD domain [PF18911.2, score=36.7]; Ion transport protein [PF00520.33, score=36.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=30.0]; WSC domain [PF01822.21, score=23.3]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=267, Expect=1e-70]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=292, Expect=3e-78]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=136, Expect=2e-31]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=297, Expect=4e-80]} {Smed: dd_Smed_v6_15525_0_1, dd_Smed_v6_15525_0_1, [Score=1504, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814}
47. MligTC455_43201 71 1.49 Mlig455_004169, Mlig455_004193

Neo: -

Age: Down-Up-Up

 0.95 - - 0.950 - - -

Mlig455_004169 {REF} {Length: 1823} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=74.3, Expect=2e-14]} {RNA1310_110906.1} {RNA815_65243}

Mlig455_004193 {REF} {Length: 1806} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=73.9, Expect=2e-14]} {RNA1310_110906.1} {RNA815_65243}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA